Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model ; volume:20 ; number:1 ; day:14 ; month:12 ; year:2024 ; pages:1-16 ; date:12.2025
Journal of neuroImmune pharmacology ; 20, Heft 1 (14.12.2024), 1-16, 12.2025
- Urheber
-
Garcia-Gomara, M.
Juan-Palencia, A.
Alfaro, M.
Cuadrado-Tejedor, M.
Garcia-Osta, A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11481-024-10164-4
- URN
-
urn:nbn:de:101:1-2502262103519.755368546940
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Garcia-Gomara, M.
- Juan-Palencia, A.
- Alfaro, M.
- Cuadrado-Tejedor, M.
- Garcia-Osta, A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Genotype-driven therapeutic developments in Parkinson’s disease
Reduced habit-driven errors in Parkinson’s Disease
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Data Driven Methods for Mobile Gait Analysis in Parkinson’s Disease
Data-Driven Models for Objective Grading Improvement of Parkinson’s Disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Genotype-driven therapeutic developments in Parkinson’s disease
Reduced habit-driven errors in Parkinson’s Disease
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Data Driven Methods for Mobile Gait Analysis in Parkinson’s Disease
Data-Driven Models for Objective Grading Improvement of Parkinson’s Disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Genotype-driven therapeutic developments in Parkinson’s disease
Reduced habit-driven errors in Parkinson’s Disease
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Data Driven Methods for Mobile Gait Analysis in Parkinson’s Disease
Data-Driven Models for Objective Grading Improvement of Parkinson’s Disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease